Mostrar el registro sencillo del ítem
| dc.contributor.author | Morales Osorio, Marco Antonio | |
| dc.contributor.author | Aguilera, Alvaro | |
| dc.contributor.author | López, Luciano | |
| dc.contributor.author | Pereira, Luis | |
| dc.contributor.author | Payares Meza, Lia Carolina | |
| dc.contributor.author | Mejía Mejía, Jeovany Andrés | |
| dc.contributor.author | Mejía Mejía, Johana Milena | |
| dc.date.accessioned | 2026-02-08T03:27:35Z | |
| dc.date.available | 2026-02-08T03:27:35Z | |
| dc.date.issued | 2025-02-01 | |
| dc.identifier.issn | 0716-4076 | |
| dc.identifier.other | Mendeley: 371dd0b3-4e71-39ef-a891-575ab4c0201a | |
| dc.identifier.uri | https://repositorio.uss.cl/handle/uss/20397 | |
| dc.description | Publisher Copyright: © 2025 Sociedad de Anestesiologia de Chile. All rights reserved. | |
| dc.description.abstract | Introduction: To better understand the risk factors associated with the severity of COVID-19, we sought to analyze the relationship between hypertension (HTN) and mortality and the need for admission to the intensive care unit (ICU) in patients with COVID-19. Methods: Databases such as Medline, Embase, CINAHL PLUS with full text, Cochrane Library Trials, Web of Science, and Scopus were consulted. Using the PRISMA-S diagram, studies were organized and tracked. Two reviewers, following PECOS criteria, evaluated and selected titles, abstracts, and full texts. Results: Out of 28 studies (n = 23,696), hypertensive patients had survival rates of 35.59%-97.47% while non-hypertensive patients had rates of 56.85%-98.34%. Hypertension was significantly associated with COVID-19 mortality (RR = 3.97, p < 0.01) and a higher need for ICU admission (14.9% vs 0.7%). Conclusions: The results indicate that HTN is a decisive factor in the progression of COVID-19 and the need for ICU admission. | en |
| dc.description.abstract | Introduction: To better understand the risk factors associated with the severity of COVID-19, we sought to analyze the relationship between hypertension (HTN) and mortality and the need for admission to the intensive care unit (ICU) in patients with COVID-19. Methods: Databases such as Medline, Embase, CINAHL PLUS with full text, Cochrane Library Trials, Web of Science, and Scopus were consulted. Using the PRISMA-S diagram, studies were organized and tracked. Two reviewers, following PECOS criteria, evaluated and selected titles, abstracts, and full texts. Results: Out of 28 studies (n = 23,696), hypertensive patients had survival rates of 35.59%-97.47% while non-hypertensive patients had rates of 56.85%-98.34%. Hypertension was significantly associated with COVID-19 mortality (RR = 3.97, p < 0.01) and a higher need for ICU admission (14.9% vs 0.7%). Conclusions: The results indicate that HTN is a decisive factor in the progression of COVID-19 and the need for ICU admission. | es |
| dc.language.iso | spa | |
| dc.relation.ispartof | vol. 54 Issue: no. 1 Pages: 27-37 | |
| dc.source | Revista Chilena de Anestesia | |
| dc.title | Arterial hypertension and mortality in ICU admission in patients with COVID-19: A systematic review and meta-analysis | es |
| dc.title.alternative | Arterial hypertension and mortality in ICU admission in patients with COVID-19A systematic review and meta-analysis | en |
| dc.type | Artículo | |
| dc.identifier.doi | 10.25237/revchilanestv54n1-03 | |
| dc.publisher.department | Facultad de Ciencias de la Rehabilitación y Calidad de Vida |
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a este ítem. |
|||